Document Page: First | Prev | Next | All | Image | This Release | Search
File: aabgl_01.txtSUBJECT: HQ USAGF; EMERGENCY MEDICAL TREATMENT AT USAF CASUALTY COLLECTION POINTS PRIORITY UNCLASSIFIED BASE COMMUNICATIONS CENTER 390 COSQ/DONA PAGE 01 OF 02 18/0300Z STRATEGIC AIR COMMAND (UNIT TOTAL: 003) OPR: SG (03) OPR: E B STRATEGIC HOSPITAL (04) INFO: FILE COPY(01) COMMAND SECT COURTESY COPY (01) ------------------------ 18/0318Z A2 03 (TOTAL COPIES: 009) PATEZYUW RUEABOL 0791 2300141- --RUCUAAA. ZNY P 172100Z AUG 90 FM HQ USAF BOLLING AFB DC//SG// TO AIG 8201//SG// RUWTENA/ 3790 MSTW SHEPPARD AFB TX// MSR// RUVKBRK/ HO HSD BROOKS AFB TX//CC//. RUVKBRK/USAFSAM BROOKS AFB TX //ED// INFO RUEADWD/DA WASHINGTON DC//SGPS-PSP/DASD-HCD-D// RULNEAA/ CDRUSAMRICD ABERDEEN PROVING GROUND MD//SGRD-UV-ZA// ZEN BUMED WASHINGTON DC//MED-02C// BT UNCLAS SUBJ: EMERGENCY MEDICAL TREATMENT AT USAF CASUALTY COLLECTION POINTS OF OPERATION DESERT SHIELD CASUALTIES EXPOSED TO NERVE AGENTS 1. A CREDIBLE THREAT OF CHEMICAL ATTACK WITH NERVE AGENTS EXISTS IN THE AREA OF RESPONSIBILITY (AOR) FOR OPERATION DESERT SHIELD. THE ATTACHED GUIDANCE ON EMERGENCY MEDICAL TREATMENT AT USAF CASUALTY COLLECTION POINTS (CCPS) HAS BEEN DEVELOPED TO MAXIMIZE THE SURVIVAL OF OPERATION DESERT SHIELD CASUALTIES EXPOSED TO NERVE AGENTS 2. MANAGE NERVE AGENT CASUALTIES AT USAF CCPS AS FOLLOWS 2A. INSURE ALL CASUALTIES ARE WEARING THEIR CHEMICAL MASK;. 2B. TRIAGE CASUALTIES AS FOLLOWS 2B1. IMMEDIATE: 2B1. 2 CONVULSIONS 2B1. 3 LOSS OF CONSCIOUSNESS 2B1. 4 OBSTRUCTIVE AIRWAY SECRETIONS 2B1. 5 CYANOSIS 2B2. DELAYED 2B2.1 PROFUSE ORAL/PHARYNGEAL SECRETIONS WITHOUT SIGNS OR SYMPTOMS OF AIRWAY OBSTRUCTION 2B2.2 MUSCLE TWITCHING/FASCICULATIONS WITH OR WITHOUT WEAKNESS 2B3. MINIMAL 2B3.1 RESOLVED SYMPTOMS WITHOUT TREATMENT OR AFTER 2 MG ATROPINE (OR 1 ATROPINE [GREEN] AUTOINJECTOR) AND/OR 1 PRALIDOXIME [BLACK] AUTOINJECTOR 2B3.2 NASAL CONGESTION 2B3.3 SEVERE EYE PAIN, BLURRED OR DIM VISION 2B3.4 SEVERE RETROBULBAR HEADACHE 2B3.5 NAUSEA 2B3.6 MILD CHEST TIGHTNESS 2B4. EXPECTANT 2B4.1 CHEMICAL AGENT EXPOSURE IN A PATIENT WITH AN 2B5. IF THE TACTICAL SITUATION ALLOWS, TREAT IMMEDIATES AS FOLLOWS: 2B5.1 ASSURE THE CASUALTY HAS RECEIVED AT LEAST 7 ML ;14 MG) OF BULK ATROPINE IM (OR 7 ATROPINE AUTOINJECTORS [GREEN] AND 3 PRALIDOXIME [BLACK] AUTOINJECTORS 2B5.2 INJECT THE CONTENTS OF ONE (1) 10 MG PRE- FILLED DIAZEPAM (VALIUM) SYRINGE DEEP INTO THE MID-ANTEROLATERAL MUSCLE OF THE THIGH; IF THE CASUALTY IS CONVULSING, DOUBLE THE DOSE 2B5.3 IF THE AIRWAY APPEARS TO BE OBSTRUCTED OR THE CASUALTY STOPS BREATHING, 2B5.3.1 REMOVE THE MASK 2B5.3.2 CLEAR THE MOUTH AND AIRWAY 2B5.3.3 INSERT AN ARTIFICIAL AIRWAY (E.G. ORAL OR NASAL AIRWAY) 2B5.3.4. REPLACE THE CASUALTY'S MASK 2B5.4 INJECT ONE ML ATROPINE IM OR ONE ATROPINE AUTOINJECTOR [GREEN] EVERY 5 MINUTES UNTIL BREATHING IS ADEQUATE AND AIRWAY SECRETIONS ARE CONTROLLED. TRY TO GET THE HEART RATE UNCLASSIFIED
Document Page: First | Prev | Next | All | Image | This Release | Search